These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3411343)

  • 1. Doxorubicin clearance in the obese.
    Rodvold KA; Rushing DA; Tewksbury DA
    J Clin Oncol; 1988 Aug; 6(8):1321-7. PubMed ID: 3411343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic profile of high-dose doxorubicin administered during a 6 h intravenous infusion in breast cancer patients].
    Wihlm J; Limacher JM; Levêque D; Duclos B; Dufour P; Bergerat JP; Methlin G
    Bull Cancer; 1997 Jun; 84(6):603-8. PubMed ID: 9295863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma pharmacokinetics and pharmacodynamics of a new prodrug N-l-leucyldoxorubicin and its metabolites in a phase I clinical trial.
    de Jong J; Geijssen GJ; Munniksma CN; Vermorken JB; van der Vijgh WJ
    J Clin Oncol; 1992 Dec; 10(12):1897-906. PubMed ID: 1453205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer.
    Swenson CE; Bolcsak LE; Batist G; Guthrie TH; Tkaczuk KH; Boxenbaum H; Welles L; Chow SC; Bhamra R; Chaikin P
    Anticancer Drugs; 2003 Mar; 14(3):239-46. PubMed ID: 12634619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of cyclosporine on the pharmacokinetics of doxorubicin in patients with small cell lung cancer.
    Rushing DA; Raber SR; Rodvold KA; Piscitelli SC; Plank GS; Tewksbury DA
    Cancer; 1994 Aug; 74(3):834-41. PubMed ID: 8039111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cimetidine disposition in obesity.
    Abernethy DR; Greenblatt DJ; Matlis R; Gugler R
    Am J Gastroenterol; 1984 Feb; 79(2):91-4. PubMed ID: 6364798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of phenytoin on the pharmacokinetics of doxorubicin and doxorubicinol in the rabbit.
    Cusack BJ; Tesnohlidek DA; Loseke VL; Vestal RE; Brenner DE; Olson RD
    Cancer Chemother Pharmacol; 1988; 22(4):294-8. PubMed ID: 3168142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution.
    Lind MJ; Margison JM; Cerny T; Thatcher N; Wilkinson PM
    Cancer Chemother Pharmacol; 1989; 25(2):139-42. PubMed ID: 2557169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I pharmacokinetic study of cyclosporin A combined with doxorubicin.
    Erlichman C; Moore M; Thiessen JJ; Kerr IG; Walker S; Goodman P; Bjarnason G; DeAngelis C; Bunting P
    Cancer Res; 1993 Oct; 53(20):4837-42. PubMed ID: 8402670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin pharmacokinetics following a single-dose infusion to sulphur-crested cockatoos (Cacatua galerita).
    Gilbert CM; Filippich LJ; Charles BG
    Aust Vet J; 2004 Dec; 82(12):769-72. PubMed ID: 15648940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicokinetics of the active doxorubicin metabolite, doxorubicinol, in sulphur-crested cockatoos (Cacatua galerita).
    Gilbert CM; Filippich LJ; McGeary RP; Charles BG
    Res Vet Sci; 2007 Aug; 83(1):123-9. PubMed ID: 17197005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and metabolism of 4'-iodo-4'-deoxy-doxorubicin in humans.
    Robert J; Armand JP; Huet S; Klink-Alakl M; Recondo G; Hurteloup P
    J Clin Oncol; 1992 Jul; 10(7):1183-90. PubMed ID: 1607922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry.
    Dobbs NA; Twelves CJ; Gillies H; James CA; Harper PG; Rubens RD
    Cancer Chemother Pharmacol; 1995; 36(6):473-6. PubMed ID: 7554038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study.
    Mross K; Niemann B; Massing U; Drevs J; Unger C; Bhamra R; Swenson CE
    Cancer Chemother Pharmacol; 2004 Dec; 54(6):514-24. PubMed ID: 15322827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of doxorubicin in patients with small cell lung cancer.
    Piscitelli SC; Rodvold KA; Rushing DA; Tewksbury DA
    Clin Pharmacol Ther; 1993 May; 53(5):555-61. PubMed ID: 8387903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration in doxorubicin and doxorubicinol plasma concentrations with repeated courses to patients.
    Morris RG; Reece PA; Dale BM; Green RM; Kotasek D; Saccoia NC; Sage RE
    Ther Drug Monit; 1989; 11(4):380-3. PubMed ID: 2741185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin disposition in obesity: clinical pharmacokinetic investigation.
    Abernethy DR; Greenblatt DJ; Smith TW
    Am Heart J; 1981 Oct; 102(4):740-4. PubMed ID: 7282520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
    Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M
    J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.